Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
5,523,842
-
Shares change
-
+186,606
-
Total reported value, excl. options
-
$187,480,258
-
Value change
-
+$1,615,681
-
Number of buys
-
47
-
Number of sells
-
-51
-
Price
-
$33.94
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2022
110 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2022.
IRADIMED CORP - Common Stock (IRMD) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,523,842 shares
of 12,733,410 outstanding shares and own 43% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (725,877 shares), RENAISSANCE TECHNOLOGIES LLC (672,578 shares), Soleus Capital Management, L.P. (620,765 shares), BlackRock Inc. (415,291 shares), VANGUARD GROUP INC (378,637 shares), RK Capital Management, LLC (299,800 shares), Russell Investments Group, Ltd. (246,264 shares), Ranger Investment Management, L.P. (198,005 shares), ACADIAN ASSET MANAGEMENT LLC (165,791 shares), and DIMENSIONAL FUND ADVISORS LP (139,928 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.